Table 3.
BMI z-score velocity (see Methods) in n = 7 patients with hypothalamic obesity undergoing individual treatment attempts with dextroamphetamine before the initiation and during the course of stimulant treatment
| Patient ID |
BMI z-score velocity before insult | BMI z-score at hypothalamic insult | BMI z-score at start dextroamphetamine | BMI z-score velocity before dextroamphetamine | BMI z-score velocity 1st year dextroamphetamine | BMI z-score velocity 2nd year dextroamphetamine | BMI z-score velocity 3rd year dextroamphetamine |
|---|---|---|---|---|---|---|---|
| 1 | n.a. | –0.30 | 1.79 | 0.60 | –0.12 | 0.22 | –0.93 |
| 2 | n.a. | 1.86 | 2.59 | n.a. | 0.04 | 0.42 | –0.06 |
| 3 | –0.5 | 1.35 | 2.58 | 0.35 | –0.21 | –0.34 | 0.17 |
| 4 | n.a. | 2.62 | 3.51 | n.a. | –0.32 | –0.21 | n.a. |
| 5 | n.a. | n.a. | 4.20 | n.a. | –0.29 | –0.13 | –0.11 |
| 6 | n.a. | 1.76 | 3.09 | 1.33 | –0.11 | 0.34 | n.a. |
| 7 | n.a. | n.a. | 4.38 | n.a. | –0.22 | n.a. | n.a. |
| Total groupa | 3.17±0.93 | –0.18±0.12 | 0.05±0.32 | –0.23±0.48 | |||
| Craniopharyngioma groupa | 2.62±0.71 | –0.15±0.15 | 0.02±0.36 | ||||
| Othersa | 3.89±0.7 | –0.21±0.09 | |||||
Mean ± standard deviation.